Anteris Technologies Global Cor

Historical 13F Holders

Symbol: AVR
CUSIP: 03675P102
All holders as of: Q2 2026
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 03675P102 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Medtronic plc 13D	16.2%	15,652,173	13D	1/29/2026 Event 1/22/2026
Medtronic plc	16.2%	15,652,173
Covidien Group S.a.r.l.	16.2%	15,652,173
L1 Capital Pty Ltd 13G/A	11.6%	11,496,345	13G/A	9/3/2026 Event 8/31/2026
FMR LLC 13G	7.5%	7,325,169	13G	8/6/2026 Event 6/30/2026
FMR LLC	7.5%	7,325,169
Abigail P. Johnson	7.5%	7,325,169
Sio Capital Management, LLC 13G/A	5.5%	5,382,965	13G/A	5/4/2026 Event 3/31/2026
BlackRock, Inc. 13G	5.0%	4,879,068	13G	4/27/2026 Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Perceptive Advisors LLC 13G/A	4.7%	1,705,130	13G/A	8/14/2025 Event 6/30/2025
Perceptive Advisors LLC	4.7%	1,705,130
Joseph Edelman	4.7%	1,705,130
Perceptive Life Sciences Master Fund, Ltd.	4.7%	1,705,130
Nantahala Capital Management, LLC 13G/A	4.1%	3,995,579	13G/A	8/14/2026 Event 6/30/2026
Nantahala Capital Management, LLC	4.1%	3,995,579
Wilmot B. Harkey	4.1%	3,995,579
Daniel Mack	4.1%	3,995,579

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	3	19.1 k	$148 k	$0
2026 Q2	146	69.0 M	$681 M	$2.32 M
2026 Q1	135	65.8 M	$365 M	$1.26 M
2025 Q4	75	21.8 M	$109 M	$0
2025 Q3	68	25.1 M	$110 M	$0
2025 Q2	62	17.1 M	$80.4 M	$0
2025 Q1	56	22.1 M	$80.2 M	$0
2024 Q4	29	16.3 M	$90.8 M	$0